Page 856 - Small Animal Clinical Nutrition 5th Edition
P. 856

Canine Cystine Urolithiasis  887



                  Treats should contain no more than 0.3% DM sodium (the  urine than cystine (dicysteine).  a
        VetBooks.ir  same as the food recommendation) and they should be limited  ond-generation cysteine chelating agent that decreases the con-
                                                                        2-MPG is commonly called tiopronin. Tiopronin is a sec-
                  to less than 10% of the daily total food regimen (volume or
                                                                      centration of cystine by a thiol-disulfide exchange reaction.
                  weight basis).
                    Another criterion for selecting a food that may become  Studies in people and dogs indicate that the drug is highly
                  increasingly important in the future is evidence-based clinical  effective in reducing urine cystine concentration and has less
                                                                                             c
                  nutrition. Practitioners should know how to determine risks  toxicity than D-penicillamine (Hoppe et al, 1988, 1993; Os-
                  and benefits of nutritional regimens and counsel pet owners  borne et al, 1989).
                  accordingly. Currently, veterinary medical education and con-  Oral administration of 2-MPG at a daily dosage of approxi-
                  tinuing education are not always based on rigorous assessment  mately 30 to 40 mg/kg of body weight (divided in two equal
                  of evidence for or against particular management options. Still,  doses) was effective in inducing dissolution of multiple cystine
                  studies have been published to establish the nutritional benefits  urocystoliths in nine of 17 dogs evaluated (Hoppe et al, 1993;
                  of certain pet foods. Chapter 2 describes evidence-based clini-  Osborne et al, 1989). Dissolution required two to four months
                  cal nutrition in detail and applies its concepts to various veteri-  of therapy. One dog developed nonpruritic vesicular skin
                  nary therapeutic foods.                             lesions following three months of therapy. One month follow-
                                                                      ing reduction of the daily dosage of 2-MPG from 30 to 25
                  Assess and Determine the Feeding Method             mg/kg of body weight, the skin lesions healed. Thrombo-
                  Transitioning a patient from its current food to a new food  cytopenia, anemia and elevated hepatic enzyme activities have
                  selected for the management of cystine uroliths should be done  also occurred in a few cystinuric dogs treated with 2-MPG
                  gradually over a period of a few days. Begin the transition by  (Osborne et al, 1989). During therapy with 2-MPG, we
                  feeding 75% of the current food and 25% of the new food on  encountered protein-losing glomerular disease in a cystinuric
                  Day 1. On Day 2, feed half of each food. On Day 3, feed 75%  dachshund.
                  of the new food and 25% of the old. By Day 4 or 5, feed only  Unfortunately, dogs that become hypersensitive to D-peni-
                  the new food.                                       cillamine may also simultaneously become hypersensitive to 2-
                    Moist foods increase water intake and produce less concen-  MPG.The beneficial action of both drugs is dose dependent as
                  trated urine; therefore, encourage clients to feed specific  are the associated side effects. To avoid this predicament when
                  amounts (meal fed) of moist food two to three times per day  thiol-containing drugs are needed, we discourage use of D-
                  rather than free-choice feeding. Moist foods can spoil if left at  penicillamine and encourage use of the less toxic 2-MPG.
                  room temperature for several hours (Chapter 11). Opened con-  Appropriate evaluations should be performed, especially if 2-
                  tainers of moist foods should be refrigerated and the feeding  MPG is used in dogs with a history of D-penicillamine hyper-
                  bowl should be kept clean.                          sensitivity.
                    Besides offering moist foods, increased water intake can be  In our experience, a combination of a litholytic food and 2-
                  facilitated by: 1) Ensuring multiple bowls are available in prom-  MPG therapy is more effective in promoting dissolution of
                  inent locations in the dog’s environment; this may mean pro-  uroliths than either alone. We induced dissolution of 18 epi-
                  viding several bowls outside in a large enclosure or a bowl on  sodes of cystine urocystoliths affecting 14 dogs using this com-
                  each level of the house. 2) Bowls should be clean and kept filled  bination of diet and drug therapy (Osborne et al, 1989). The
                  with fresh water. 3) Small amounts of flavoring substances (e.g.,  mean time required to dissolve the cystine uroliths was 78 days
                  salt-free bouillon) can be added to water sources to encourage  (range 11 to 211 days).
                  consumption. 4) Ice cubes can be offered as treats or snacks. 5)
                  If a dry food is selected, ask the client to add liberal quantities  D-Penicillamine
                                                                                   c
                  of water; however, as with moist foods left at room temperature  D-penicillamine, also called dimethylcysteine, is commonly
                  for prolonged intervals, potential food safety issues might arise  referred to as a first-generation cysteine chelating drug. It is a
                  (Chapter 11).                                       nonmetabolizable degradation product of penicillin that may
                    If the patient has a normal body condition score (BCS 2.5/5  combine with cysteine to form cysteine-D-penicillamine disul-
                  to 3.5/5), the amount of the previous food being fed was appro-  fide (Bovee, 1984a). This disulfide exchange reaction is facili-
                  priate. On an energy basis, a similar amount of the new food  tated by an alkaline pH. The resulting compound has been re-
                  would probably be a good starting place.            ported to be 50 times more soluble than free cystine (Lotz et al,
                                                                      1966). The cysteine-D-penicillamine complex does not react
                                                                      with nitroprusside as does cystine, providing a marker to aid in
                   ADJUNCTIVE MEDICAL MANAGEMENT                      titrating dosage of the drug (Pahira, 1987).
                                                                        Although D-penicillamine is effective in reducing urine cys-
                  Thiol-Containing Drugs                              tine concentrations, drug-related adverse events limit its use.
                  2-MPG                                               With the availability of 2-MPG, we have discontinued use of
                  Drugs that increase the solubility of cystine in urine contain a  D-penicillamine.
                  thiol group that can dissociate and then bind with the sulfide  The most commonly used dosage of D-penicillamine for
                  moiety of cysteine.The resulting complexes are more soluble in  dogs has been 30 mg/kg body weight/day given in two divided
   851   852   853   854   855   856   857   858   859   860   861